While the reduction in price target from $95 to $90 by BMO Capital could be seen as a negative signal, the maintenance of an Outperform rating suggests that the analyst still sees positive growth prospects for Goosehead Insurance. This mixed signal could lead to a neutral short-term impact on the stock price as investors weigh the lowered price target against the continued positive outlook.